Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Bauer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|January 1, 1981
Failure of conventional treatment to prevent relapse of hepatic amoebiasisA G Bauer, S W Schalm, P C Stuiver
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
The kidney is the main site of prolactin elimination in patients with liver diseaseA G Bauer, J H Wilson, S W Lamberts
Hormone Research|January 1, 1982
Peripheral elimination of growth hormone in chronic liver diseaseA G Bauer, S W Lamberts, J H Wilson
Hepato-Gastroenterology|October 1, 1983
Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acidsA G Bauer, J H Wilson, S W Lamberts, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1986
Seizures associated with oxamniquine therapyH Stokvis, A G Bauer, P C Stuiver, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Convulsions after oxamniquineH Stokvis, A G Bauer, P C Stuiver, et al.
Acta Endocrinologica|November 1, 1987
Handling of iodothyronines by the liver and kidney in patients with chronic liver diseaseA G Bauer, J H Wilson, S W Lamberts, et al.
Gastroenterology|February 1, 1982
hyperprolactinemia of portal hypertension in ratsA G Bauer, W J de Greef, F H de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 22, 1982
[LeVeen's peritoneojugular shunt for the treatment of ascites]R J Ouwendijk, S W Schalm, A G Bauer, et al.
Drug and Alcohol Dependence|January 25, 2023
Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristicsL M Ruglass, A Shevorykin, Y Zhao, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|January 1, 1981
Failure of conventional treatment to prevent relapse of hepatic amoebiasisA G Bauer, S W Schalm, P C Stuiver
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
The kidney is the main site of prolactin elimination in patients with liver diseaseA G Bauer, J H Wilson, S W Lamberts
Hormone Research|January 1, 1982
Peripheral elimination of growth hormone in chronic liver diseaseA G Bauer, S W Lamberts, J H Wilson
Hepato-Gastroenterology|October 1, 1983
Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acidsA G Bauer, J H Wilson, S W Lamberts, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1986
Seizures associated with oxamniquine therapyH Stokvis, A G Bauer, P C Stuiver, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Convulsions after oxamniquineH Stokvis, A G Bauer, P C Stuiver, et al.
Acta Endocrinologica|November 1, 1987
Handling of iodothyronines by the liver and kidney in patients with chronic liver diseaseA G Bauer, J H Wilson, S W Lamberts, et al.
Gastroenterology|February 1, 1982
hyperprolactinemia of portal hypertension in ratsA G Bauer, W J de Greef, F H de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 22, 1982
[LeVeen's peritoneojugular shunt for the treatment of ascites]R J Ouwendijk, S W Schalm, A G Bauer, et al.
Drug and Alcohol Dependence|January 25, 2023
Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristicsL M Ruglass, A Shevorykin, Y Zhao, et al.
Pageof 1